Financial Times

myFT Instant Alert

UK companies

Drug groups unveil advances in treating most difficult breast cancers

AstraZeneca, Daiichi Sankyo and Gilead report promising trial results in ‘triple negative’ breast cancer

OCTOBER 19, 2025 by Hannah Kuchler in London and Patrick Temple-West in New York

For more new articles on topics you follow visit your myFT feed

FT Live @ COP30 | November 2025

This November, the global climate agenda converges in Belém, Brazil. FT Live @ COP30 will bring together leaders, investors, NGOs and policymakers to examine the decisions shaping global climate action.

Join FT journalists and global voices for debates, analysis and insights from the frontline of climate action.

Manage the emails you receive in your Contact Preferences

Unsubscribe from myFT Instant Alerts for UK companies

Terms & conditions ‌ ‌ ‌ ‌ Privacy Policy ‌ ‌ ‌ ‌ Cookie Policy ‌ ‌ ‌ ‌ View online ‌ ‌ ‌ ‌

You have received this email because you have signed up from the Emails & Alerts page. This email was sent by a company owned by Financial Times Group Limited (FT Group), registered office at Bracken House, 1 Friday Street, London EC4M 9BT. Registered in England and Wales with company number 879531.